Simplify® Cervical Artificial Disc

FDA premarket approval P200022 · Prosthesis, intervertebral disc

PMA numberP200022

Approval

Applicant
Globus Medical, Inc.
Received
March 25, 2020
Decision date
September 18, 2020 (APPR)
Supplements
17, latest June 5, 2025
Product code
MJO – Prosthesis, Intervertebral Disc

Official FDA PMA record

Approval order statement

Approval for Simplify® Cervical Artificial Disc that is indicated for use in skeletally mature patients for reconstruction of the disc at one level from C3-C7 following single-level discectomy for intractable radiculopathy (arm pain and/or a neurological deficit) with or without neck pain, or myelopathy due to a single-level abnormality localized to the level of the disc space and manifested by at least one of the following conditions confirmed by radiographic imaging (e.g., X-rays, computed tomography (CT), magnetic resonance imaging (MRI)): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height as compared to adjacent levels. Patients receiving Simplify® Cervical Artificial Disc should have failed at least six weeks of non-operative treatment or have the presence of progressive symptoms (e.g., numbness or tingling) prior to implantation. Simplify® Cervical Artificial Disc is implanted via an open anterior approach.